Literature DB >> 15746302

Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing.

Siva Raja1, Jesus Ching, Liqiang Xi, Steven J Hughes, Ronald Chang, Wendy Wong, William McMillan, William E Gooding, Kenneth S McCarty, Melissa Chestney, James D Luketich, Tony E Godfrey.   

Abstract

BACKGROUND: PCR-based assays can improve clinical care, but they remain technically demanding and labor-intensive. We describe a new instrument, the GeneXpert, that performs automated nucleic acid isolation, reverse transcription, and fluorescence-based quantitative PCR in approximately 35 min.
METHODS: Yield and integrity of RNA isolated on the GeneXpert were compared with Qiagen-based extraction for parallel samples (5-microm frozen tissue sections). The reproducibility of automated RNA isolation, reverse transcription, and quantitative PCR was determined by replicate (n = 10) analysis of 10 tissues, using duplex (target and endogenous control) reverse transcription-PCR reactions for two gene combinations. The GeneXpert was then used to perform rapid analysis of lymph nodes from melanoma, breast cancer, and lung cancer patients and analysis of melanoma metastatic to the lung, primary lung adenocarcinoma, and healthy lung tissue.
RESULTS: On the GeneXpert, RNA was recovered in slightly over 6 min, and the yield was approximately 70% of that from parallel Qiagen reactions. The RNA integrity was comparable to that of Qiagen-isolated RNA as determined by gel electrophoresis. For the melanoma samples, the 95% prediction interval for the deltaCt for a new measurement was +/-1.54 cycles, and for breast cancer samples, the interval for a newly observed deltaCt was +/-1.40 cycles. GeneXpert assays successfully detected the presence of metastatic melanoma, breast cancer, and lung cancer in lymph nodes and also differentiated among metastatic melanoma, lung adenocarcinoma, and healthy lung.
CONCLUSIONS: RNA yield and integrity on the GeneXpert are comparable to benchtop methods. Reproducibility of the GeneXpert data is similar to that seen with manual methods in our hands but may need improvement for some applications. The GeneXpert can perform RNA isolation, reverse transcription, and quantitative PCR in approximately 35 min and could therefore be used for intraoperative testing when applicable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746302     DOI: 10.1373/clinchem.2004.046474

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  38 in total

1.  GeneXpert in the diagnosis of risk factors for thrombophilia: evaluation of its use in a small laboratory.

Authors:  Gianluca Gessoni; Sara Valverde Sara; Rosa Canistro; Fabio Manoni
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

2.  Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens.

Authors:  Arzu N Zeka; Sezai Tasbakan; Cengiz Cavusoglu
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

3.  Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes.

Authors:  Sa Deepak; Kr Kottapalli; R Rakwal; G Oros; Ks Rangappa; H Iwahashi; Y Masuo; Gk Agrawal
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

4.  A quantitative reverse transcription-PCR assay for rapid, automated analysis of breast cancer sentinel lymph nodes.

Authors:  Steven J Hughes; Liqiang Xi; William E Gooding; David J Cole; Michael Mitas; John Metcalf; Rohit Bhargava; David Dabbs; Jesus Ching; Lynn Kozma; William McMillan; Tony E Godfrey
Journal:  J Mol Diagn       Date:  2009-10-01       Impact factor: 5.568

5.  Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Catharina Boehme; Elvira Richter
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

6.  Evaluation of rapid GeneXpert MTB/RIF method using DNA tissue specimens of vertebral bones in patients with suspected spondylitis TB.

Authors:  Muhammad Nasrum Massi; Karya Triko Biatko; Irda Handayani; Muhammad Yogi Pratama; Sari Septriani; Gaby Maulida Nurdin; Marina B Ali
Journal:  J Orthop       Date:  2017-01-09

7.  Development of a panel of recombinase polymerase amplification assays for detection of common bacterial urinary tract infection pathogens.

Authors:  B Raja; H J Goux; A Marapadaga; S Rajagopalan; K Kourentzi; R C Willson
Journal:  J Appl Microbiol       Date:  2017-08       Impact factor: 3.772

8.  Diagnostic tools for tackling febrile illness and enhancing patient management.

Authors:  Konstantinos Mitsakakis; Valérie D'Acremont; Sebastian Hin; Felix von Stetten; Roland Zengerle
Journal:  Microelectron Eng       Date:  2018-10-05       Impact factor: 2.523

Review 9.  Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries.

Authors:  Angelika Niemz; David S Boyle
Journal:  Expert Rev Mol Diagn       Date:  2012-09       Impact factor: 5.225

10.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.